These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34900540)

  • 21. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy.
    Cheng X; He L; Xu J; Fang Q; Yang L; Xue Y; Wang X; Tang R
    Acta Biomater; 2020 Aug; 112():234-249. PubMed ID: 32502633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA.
    Yuan Y; Liu J; Yu X; Liu X; Cheng Y; Zhou C; Li M; Shi L; Deng Y; Liu H; Wang G; Wang L; Wang Z
    Acta Biomater; 2021 Nov; 135():556-566. PubMed ID: 34496281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hybrid Prodrug Nanoparticles with Tumor Penetration and Programmed Drug Activation for Enhanced Chemoresistant Cancer Therapy.
    Zhao C; Shao L; Lu J; Deng X; Tong Y; Wu Y
    ACS Appl Mater Interfaces; 2017 Jun; 9(22):18450-18461. PubMed ID: 28513140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deep Tumor Penetration of Doxorubicin-Loaded Glycol Chitosan Nanoparticles Using High-Intensity Focused Ultrasound.
    Choi Y; Han H; Jeon S; Yoon HY; Kim H; Kwon IC; Kim K
    Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33076520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detachable Dual-Targeting Nanoparticles for Improving the Antitumor Effect by Extracellular Matrix Depletion.
    Duan S; Sun F; Qiao P; Zhu Z; Geng M; Gong X; Li Y; Yao H
    ACS Biomater Sci Eng; 2023 Mar; 9(3):1437-1449. PubMed ID: 36795746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced chemotherapeutic efficacy of the low-dose doxorubicin in breast cancer via nanoparticle delivery system crosslinked hyaluronic acid.
    Wang Q; Zhong Y; Liu W; Wang Z; Gu L; Li X; Zheng J; Du H; Zhong Z; Xie F
    Drug Deliv; 2019 Dec; 26(1):12-22. PubMed ID: 30691317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An oxygen self-sufficient NIR-responsive nanosystem for enhanced PDT and chemotherapy against hypoxic tumors.
    Yang G; Tian J; Chen C; Jiang D; Xue Y; Wang C; Gao Y; Zhang W
    Chem Sci; 2019 Jun; 10(22):5766-5772. PubMed ID: 31293763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioconjugated Manganese Dioxide Nanoparticles Enhance Chemotherapy Response by Priming Tumor-Associated Macrophages toward M1-like Phenotype and Attenuating Tumor Hypoxia.
    Song M; Liu T; Shi C; Zhang X; Chen X
    ACS Nano; 2016 Jan; 10(1):633-647. PubMed ID: 26650065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid pH-responsive self-disintegrating nanoassemblies balance tumor accumulation and penetration for enhanced anti-breast cancer therapy.
    Li J; Wang Y; Xu C; Yu Q; Wang X; Xie H; Tian L; Qiu Y; Guo R; Lu Z; Li M; He Q
    Acta Biomater; 2021 Oct; 134():546-558. PubMed ID: 33882357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Tumor Microenvironment Destroyer for Efficient Cancer Suppression.
    Yao H; Xu K; Zhou J; Zhou L; Wei S
    ACS Biomater Sci Eng; 2020 Jan; 6(1):450-462. PubMed ID: 33463237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
    Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
    Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyaluronic acid-modified manganese dioxide-enveloped hollow copper sulfide nanoparticles as a multifunctional system for the co-delivery of chemotherapeutic drugs and photosensitizers for efficient synergistic antitumor treatments.
    Li X; Pan Y; Zhou J; Yi G; He C; Zhao Z; Zhang Y
    J Colloid Interface Sci; 2022 Jan; 605():296-310. PubMed ID: 34329981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-Supply of O
    Gao S; Jin Y; Ge K; Li Z; Liu H; Dai X; Zhang Y; Chen S; Liang X; Zhang J
    Adv Sci (Weinh); 2019 Dec; 6(24):1902137. PubMed ID: 31871871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbon nanotubes for delivery of small molecule drugs.
    Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G
    Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future development.
    Sun Y; Zhao D; Wang G; Wang Y; Cao L; Sun J; Jiang Q; He Z
    Acta Pharm Sin B; 2020 Aug; 10(8):1382-1396. PubMed ID: 32963938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-Switchable DNA Programmed Disassembly of Nanoparticles for Smart Size Tunability and Cancer-Specific Drug Release.
    Ye W; Chen X; Li X; Liu Y; Jia F; Jin Q; Ji J
    ACS Appl Mater Interfaces; 2020 May; 12(20):22560-22571. PubMed ID: 32338490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microwave-Triggered Smart Drug Release from Liposomes Co-encapsulating Doxorubicin and Salt for Local Combined Hyperthermia and Chemotherapy of Cancer.
    Jin Y; Liang X; An Y; Dai Z
    Bioconjug Chem; 2016 Dec; 27(12):2931-2942. PubMed ID: 27998076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
    Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
    Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery.
    Tam YT; To KK; Chow AH
    Colloids Surf B Biointerfaces; 2016 Mar; 139():249-58. PubMed ID: 26724466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fullerene (C60)-based tumor-targeting nanoparticles with "off-on" state for enhanced treatment of cancer.
    Shi J; Wang B; Wang L; Lu T; Fu Y; Zhang H; Zhang Z
    J Control Release; 2016 Aug; 235():245-258. PubMed ID: 27276066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.